2018 Q1 Form 10-Q Financial Statement
#000114420418028602 Filed on May 15, 2018
Income Statement
Concept | 2018 Q1 | 2017 Q1 |
---|---|---|
Revenue | $1.149M | $434.5K |
YoY Change | 164.52% | 248.44% |
Cost Of Revenue | $587.5K | $341.0K |
YoY Change | 72.26% | 15.68% |
Gross Profit | $561.9K | $93.47K |
YoY Change | 501.16% | -154.95% |
Gross Profit Margin | 48.89% | 21.51% |
Selling, General & Admin | $1.675M | $1.017M |
YoY Change | 64.66% | 71.17% |
% of Gross Profit | 298.16% | 1088.54% |
Research & Development | $49.67K | $44.70K |
YoY Change | 11.11% | -47.79% |
% of Gross Profit | 8.84% | 47.83% |
Depreciation & Amortization | $4.317K | $447.00 |
YoY Change | 865.77% | |
% of Gross Profit | 0.77% | 0.48% |
Operating Expenses | $1.725M | $1.208M |
YoY Change | 42.84% | 47.53% |
Operating Profit | -$1.163M | -$1.114M |
YoY Change | 4.39% | 12.69% |
Interest Expense | $237.00 | $164.00 |
YoY Change | 44.51% | -100.15% |
% of Operating Profit | ||
Other Income/Expense, Net | $465.00 | $310.9K |
YoY Change | -99.85% | -108.83% |
Pretax Income | -$1.160M | -$800.0K |
YoY Change | 45.0% | -82.26% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$1.163M | -$803.2K |
YoY Change | 44.75% | -82.19% |
Net Earnings / Revenue | -101.15% | -184.85% |
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$179.3K | -$178.6K |
COMMON SHARES | ||
Basic Shares Outstanding | 112.0M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2018 Q1 | 2017 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $1.280M | $780.0K |
YoY Change | 64.1% | -30.97% |
Cash & Equivalents | $1.277M | $783.7K |
Short-Term Investments | $0.00 | $0.00 |
Other Short-Term Assets | $90.00K | $10.00K |
YoY Change | 800.0% | -75.0% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $137.3K | $57.60K |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $1.510M | $860.0K |
YoY Change | 75.58% | -27.73% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $41.57K | $5.289K |
YoY Change | 685.97% | |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $60.00K | |
YoY Change | ||
Total Long-Term Assets | $2.910M | $2.920M |
YoY Change | -0.34% | -15.21% |
TOTAL ASSETS | ||
Total Short-Term Assets | $1.510M | $860.0K |
Total Long-Term Assets | $2.910M | $2.920M |
Total Assets | $4.420M | $3.780M |
YoY Change | 16.93% | -18.42% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $60.00K | $260.0K |
YoY Change | -76.92% | -3.7% |
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $20.00K | |
YoY Change | 0.0% | |
Total Short-Term Liabilities | $1.449M | $3.930M |
YoY Change | -63.14% | -11.36% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | -100.0% | |
Other Long-Term Liabilities | $10.00K | $10.00K |
YoY Change | 0.0% | |
Total Long-Term Liabilities | $10.00K | $10.00K |
YoY Change | 0.0% | -99.49% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $1.449M | $3.930M |
Total Long-Term Liabilities | $10.00K | $10.00K |
Total Liabilities | $1.458M | $3.950M |
YoY Change | -63.08% | -38.25% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$38.29M | -$34.62M |
YoY Change | 10.58% | 20.42% |
Common Stock | $1.617K | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $2.965M | -$164.3K |
YoY Change | ||
Total Liabilities & Shareholders Equity | $4.423M | $3.781M |
YoY Change | 16.98% | -18.4% |
Cashflow Statement
Concept | 2018 Q1 | 2017 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$1.163M | -$803.2K |
YoY Change | 44.75% | -82.19% |
Depreciation, Depletion And Amortization | $4.317K | $447.00 |
YoY Change | 865.77% | |
Cash From Operating Activities | -$596.7K | -$613.0K |
YoY Change | -2.66% | 9.47% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $10.89K | $5.736K |
YoY Change | 89.91% | |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | -$86.72K | -$56.71K |
YoY Change | 52.93% | 41.77% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | $0.00 | $50.00K |
YoY Change | -100.0% | |
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 0.000 | $44.00K |
YoY Change | -100.0% | -540.0% |
NET CHANGE | ||
Cash From Operating Activities | -596.7K | -$613.0K |
Cash From Investing Activities | -86.72K | -$56.71K |
Cash From Financing Activities | 0.000 | $44.00K |
Net Change In Cash | -683.4K | -$625.8K |
YoY Change | 9.22% | 2.58% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$596.7K | -$613.0K |
Capital Expenditures | $10.89K | $5.736K |
Free Cash Flow | -$607.6K | -$618.8K |
YoY Change | -1.81% | 10.5% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2017Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
341042 | USD |
CY2017Q1 | us-gaap |
Gross Profit
GrossProfit
|
93465 | USD |
CY2018Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4423331 | USD |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5034388 | USD |
CY2018Q1 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
14467 | USD |
CY2017Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
23535 | USD |
CY2018Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1448678 | USD |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4333329 | USD |
CY2018Q1 | us-gaap |
Liabilities
Liabilities
|
1458465 | USD |
CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
4338377 | USD |
CY2018Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
1 | USD |
CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
1 | USD |
CY2018Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
1617 | USD |
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1617 | USD |
CY2018Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-38285838 | USD |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-39425900 | USD |
CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2964866 | USD |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
696011 | USD |
CY2018Q1 | us-gaap |
Cash
Cash
|
1276997 | USD |
CY2017Q4 | us-gaap |
Cash
Cash
|
1960430 | USD |
CY2018Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
137329 | USD |
CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
105817 | USD |
CY2018Q1 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
978 | USD |
CY2018Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
1724954 | USD |
CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1114133 | USD |
CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1163076 | USD |
CY2017Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
164 | USD |
CY2018Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
587464 | USD |
CY2018Q1 | us-gaap |
Gross Profit
GrossProfit
|
561878 | USD |
CY2017Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
279727 | USD |
CY2018Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
610662 | USD |
CY2017Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
44702 | USD |
CY2018Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
49667 | USD |
CY2017Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
737681 | USD |
CY2018Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
936960 | USD |
CY2017Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
145488 | USD |
CY2018Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
127665 | USD |
CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
1207598 | USD |
CY2018Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
237 | USD |
CY2017Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
310937 | USD |
CY2018Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
465 | USD |
CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-803196 | USD |
CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1162611 | USD |
CY2017Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
750 | USD |
CY2017Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
1233754 | USD |
CY2017Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
2984010 | USD |
CY2018Q1 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
3319 | USD |
CY2017Q4 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
9402 | USD |
CY2018Q1 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
9787 | USD |
CY2017Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
783664 | USD |
CY2018Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1276997 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-18923 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-5871 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
69959 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
140464 | USD |
CY2017Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
5048 | USD |
CY2018Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
41570 | USD |
CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
34994 | USD |
CY2018Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
41249086 | USD |
CY2017Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
40120293 | USD |
CY2018Q1 | us-gaap |
Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
|
13750 | USD |
CY2018Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1176361 | USD |
CY2017Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
434507 | USD |
CY2018Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1149342 | USD |
CY2018Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
0 | USD |
CY2017Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
310773 | USD |
CY2018Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
228 | USD |
CY2017Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
0 | USD |
CY2018Q1 | aeye |
Adjustments To Additional Paid In Capital Restricted Stock Units Warrant And Options Issued For Services
AdjustmentsToAdditionalPaidInCapitalRestrictedStockUnitsWarrantAndOptionsIssuedForServices
|
367303 | USD |
CY2017Q1 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
145488 | USD |
CY2018Q1 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
127665 | USD |
CY2017Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
211464 | USD |
CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
367303 | USD |
CY2017Q1 | aeye |
Common Stock Issuance Costs
CommonStockIssuanceCosts
|
17875 | USD |
CY2018Q1 | aeye |
Common Stock Issuance Costs
CommonStockIssuanceCosts
|
0 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
12954 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
31512 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
11853 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-25954 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
51750 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
-9068 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-613048 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-596715 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-56706 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-86718 | USD |
CY2017Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
50000 | USD |
CY2018Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
44000 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | USD |
CY2017Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-625754 | USD |
CY2018Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-683433 | USD |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1409418 | USD |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1960430 | USD |
CY2017Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
CY2018Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
|
1344 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
|
385 | USD |
CY2018Q1 | us-gaap |
Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
|
0 | USD |
CY2018Q1 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2017Q1 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2017Q1 | us-gaap |
Restricted Stock Expense
RestrictedStockExpense
|
0 | USD |
CY2018Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00001 | |
CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00001 | |
CY2018Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2018Q1 | us-gaap |
Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
|
0 | USD |
CY2017Q1 | us-gaap |
Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
|
6062 | USD |
CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
10893 | USD |
CY2017Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
5736 | USD |
CY2017Q1 | aeye |
Restricted Stock Units Issued In Payment Of Accrued Compensation
RestrictedStockUnitsIssuedInPaymentOfAccruedCompensation
|
58333 | USD |
CY2018Q1 | aeye |
Restricted Stock Units Issued In Payment Of Accrued Compensation
RestrictedStockUnitsIssuedInPaymentOfAccruedCompensation
|
0 | USD |
CY2018Q1 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
75825 | USD |
CY2017Q1 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
50970 | USD |
CY2018Q1 | aeye |
Working Capital Amount
WorkingCapitalAmount
|
59041 | USD |
CY2018Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
35968 | USD |
CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
31651 | USD |
CY2018Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
77538 | USD |
CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
66645 | USD |
CY2018Q1 | us-gaap |
Depreciation
Depreciation
|
4317 | USD |
CY2017Q1 | us-gaap |
Depreciation
Depreciation
|
447 | USD |
CY2018Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2661963 | USD |
CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2538615 | USD |
CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2164463 | USD |
CY2018Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2116940 | USD |
CY2017Q4 | aeye |
Due To Related Party For Unreimbursed Travel Related Expenses
DueToRelatedPartyForUnreimbursedTravelRelatedExpenses
|
14000 | USD |
CY2018Q1 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
10507 | USD |
CY2017Q1 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1500 | USD |
CY2018Q1 | us-gaap |
Restricted Stock Expense
RestrictedStockExpense
|
220864 | USD |
CY2018Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
|
179563 | USD |
CY2018Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
110000 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
110000 | shares |
CY2018Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
110000 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
110000 | shares |
CY2018Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2018Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | shares |
CY2018Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
161664077 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
161664077 | shares |
CY2018Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
161664077 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
161664077 | shares |
CY2018Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
161664077 | shares |
CY2017Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
111884024 | shares |
CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2017Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2018Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <font style="BACKGROUND-COLOR: transparent"><u>Use of Estimates</u></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2018Q1 | aeye |
Due To Related Party For Unreimbursed Travel Related Expenses
DueToRelatedPartyForUnreimbursedTravelRelatedExpenses
|
8475 | USD |
CY2018Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
81744441 | shares |
CY2017Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
98181910 | shares |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1509436 | shares |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.258 | |
CY2018Q1 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
43932 | USD |
CY2017Q4 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
0 | USD |
CY2018Q1 | us-gaap |
Deferred Costs
DeferredCosts
|
56574 | USD |
CY2017Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
0 | USD |
CY2018Q1 | us-gaap |
Deferred Policy Acquisition Costs Text Block1
DeferredPolicyAcquisitionCostsTextBlock1
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>NOTE 5 — DEFERRED COSTS</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Effective January 1, 2018, the Company capitalizes initial and renewal sales commission payments in the period a customer contract is obtained and payment is received; and is amortized consistent with the transfer of the goods or services to the customer over the expected period of benefit. The expected period of benefit is the contract term, except when the commission payment is expected to provide economic benefit to the Company for a period longer than the contract term, such as for new customer or incremental sales where renewals are expected and renewal commissions are not commensurate with initial commissions.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Such commissions are amortized over the greater of contract term or technological obsolescence period when the underlying contracted products are technology-based, such as for the SaaS-based platforms, or the expected customer relationship period when the underlying contracted products are not technology-based, such as for patient experience survey products.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">During the three months ended March 31, 2018, the Company deferred an aggregate $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30,327</font> commissions paid and reclassified from equity $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">80,153</font> previously paid and expensed commissions. Amortization of deferred costs for the three months ended March 31, 2018 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,974</font>.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2018Q1 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
9974 | USD |
CY2017Q1 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
0 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
30327 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
0 | USD |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
|
The options are exercisable at $0.258 per share for five years with (i) 946,936 options vesting 50% at the first day of each month beginning January 1, 2018 through December 1, 2018, 25% vesting at the first day of each month from January 1, 2019 through December 1, 2019 and 25% vesting at the first day of each month beginning January 1, 2020 through December 1, 2020; (ii) 312,500 options vesting 50% on January 1, 2018, 50% vesting at each month beginning on January 1, 2019 for 24 months; and (iii) 250,000 options fully vesting on January 1, 2018. The exercise price was determined using the 10-day average closing price beginning with the closing price on January 9, 2018. | |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
298914 | shares |
CY2018Q1 | us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
857003 | USD |
CY2018Q1 | aeye |
Deferred Revenue Payments
DeferredRevenuePayments
|
997467 | USD |